PTPRG
PTPRG (protein tyrosine phosphatase receptor type G, also known as RPTPG or PTPG) is a receptor-type protein tyrosine phosphatase with tyrosine phosphatase activity. It belongs to the receptor class 5 subfamily and is considered a candidate tumour suppressor. Browse Assay Genie's current range of PTPRG research reagents below, or read on for the biology behind the target.
PTPRG is a protein tyrosine phosphatase, an enzyme that removes phosphate groups from tyrosine residues. Protein tyrosine phosphatases (PTPs) are signalling molecules that regulate a variety of cellular processes, including cell growth, differentiation, the mitotic cycle and oncogenic transformation. PTPRG is a receptor-type PTP: it has an extracellular region, a single transmembrane region and two tandem intracytoplasmic catalytic domains, and it is found at the membrane.
The extracellular region of PTPRG contains a carbonic anhydrase-like (CAH) domain. This domain is also present in the extracellular region of PTPRBETA/ZETA, which places the two proteins close together structurally. UniProt classifies the protein in the protein-tyrosine phosphatase family, receptor class 5 subfamily, and HGNC lists it within the fibronectin type III domain containing group and the receptor-type protein tyrosine phosphatases. The mouse ortholog is Ptprg.
The PTPRG gene lies in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma. For this reason it is thought to be a candidate tumour suppressor gene. Researchers studying phosphotyrosine signalling and cancer biology therefore work with the PTPRG protein and gene, as well as with tools such as a PTPRG antibody or PTPRG ELISA kit. Other names in use are RPTPG and PTPG.
PTPRG possesses tyrosine phosphatase activity, and PTPs regulate cell growth, differentiation and the mitotic cycle.
The PTPRG gene sits in a region frequently deleted in renal cell and lung carcinoma, making it a candidate tumour suppressor.
PTPRG combines a carbonic anhydrase-like extracellular domain, one transmembrane region and two tandem catalytic domains.
PTPs are signalling molecules implicated in oncogenic transformation, so PTPRG is relevant to studies of how phosphorylation balance affects cell behaviour.
PTPRG possesses tyrosine phosphatase activity. As a member of the PTP family, it belongs to a group of signalling molecules that regulate cell growth, differentiation, the mitotic cycle and oncogenic transformation. It is a receptor-type enzyme located at the membrane.
PTPRG is also written RPTPG or PTPG, and its full name is protein tyrosine phosphatase receptor type G. UniProt names it receptor-type tyrosine-protein phosphatase gamma. HGNC records no previous gene names for it.
The PTPRG gene is in a chromosomal region frequently deleted in renal cell carcinoma and lung carcinoma. For that reason it is thought to be a candidate tumour suppressor. The mouse ortholog is Ptprg; check the datasheet of any product for its validated reactivity.
Other receptor-type protein tyrosine phosphatases and phosphatase tumour suppressors that may interest researchers working on phosphotyrosine signalling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P23470; product specifications from Assay Genie datasheets.